Science & Enterprise subscription

Follow us on Twitter

  • A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial p… https://t.co/iByygVnB9U
    about 16 hours ago
  • New post on Science and Enterprise: Covid-19 Drug Biotech Raises $300M in IPO https://t.co/zwkRakiFk5 #Science #Business
    about 16 hours ago
  • The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infec… https://t.co/9zAfSK9Nnt
    about 21 hours ago
  • New post on Science and Enterprise: FDA to Use Lung Chip Model for Covid-19 Testing https://t.co/YGwasY1UUJ #Science #Business
    about 21 hours ago
  • Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among… https://t.co/bm7JdQ83hT
    about 2 days ago

Please share Science & Enterprise

Start-Up Developing Engineered B-Cell Therapies

Human B-cell

A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system. . . . → Read More: Start-Up Developing Engineered B-Cell Therapies

Q3 Venture Funds Inch Up, Early-Stage Deals Drop

Early-stage venture Q3 2020

Venture capital funding rose in the third quarter of 2020, driven in large part by investments in already established companies rather than newer enterprises. . . . → Read More: Q3 Venture Funds Inch Up, Early-Stage Deals Drop

New Company IDs Drugs Targeting Cancer Cell Networks

Cancer magnified

A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks

Microbiome Therapies Company Unveils, Raises $50M

Microbiome graphic

A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer. . . . → Read More: Microbiome Therapies Company Unveils, Raises $50M

Infographic – Global Climate Technology Hubs

Chart: climate tech hubs

The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic. . . . → Read More: Infographic – Global Climate Technology Hubs

Chip-Based RNA Biotech Raises $60M in Venture Funds

DNA chip graphic

A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its second venture funding round. . . . → Read More: Chip-Based RNA Biotech Raises $60M in Venture Funds

Precision Cancer Therapy Start-Up Gains $110M in Early Funds

Human T-cell

A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds

Antibody Discovery Company Forms, Partners on Covid-19

Network pointer

A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments. . . . → Read More: Antibody Discovery Company Forms, Partners on Covid-19

Digital Sedation Company Raises $11.8M in Early Funds

Sedakit

A Belgian company creating virtual reality systems for sedation in surgery and invasive procedures is raising €10 million in its first venture funding round. . . . → Read More: Digital Sedation Company Raises $11.8M in Early Funds

Infographic – Biotech Index Cruising in High Range

NBI, Feb - Aug 2020

Looking back to May shows that NBI has largely settled in to the 4,000 to 4,500 range, without volatile swings in either direction. . . . → Read More: Infographic – Biotech Index Cruising in High Range